These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 23552512

  • 1. New approaches for understanding mechanisms of drug resistance in schistosomes.
    Greenberg RM.
    Parasitology; 2013 Oct; 140(12):1534-46. PubMed ID: 23552512
    [Abstract] [Full Text] [Related]

  • 2. Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel.
    Kasinathan RS, Sharma LK, Cunningham C, Webb TR, Greenberg RM.
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3265. PubMed ID: 25330312
    [Abstract] [Full Text] [Related]

  • 3. ABC multidrug transporters in schistosomes and other parasitic flatworms.
    Greenberg RM.
    Parasitol Int; 2013 Dec; 62(6):647-53. PubMed ID: 23474413
    [Abstract] [Full Text] [Related]

  • 4. Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel.
    Kasinathan RS, Goronga T, Messerli SM, Webb TR, Greenberg RM.
    FASEB J; 2010 Jan; 24(1):128-35. PubMed ID: 19726755
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W, Wang W, Huang YX.
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N, Gouveia MJ, Rinaldi G, Brindley PJ, Gärtner F, Correia da Costa JM.
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [Abstract] [Full Text] [Related]

  • 9. Schistosomiasis control: praziquantel forever?
    Cioli D, Pica-Mattoccia L, Basso A, Guidi A.
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ, Cioli D, Utzinger J.
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
    Chienwichai P, Tipthara P, Tarning J, Limpanont Y, Chusongsang P, Chusongsang Y, Adisakwattana P, Reamtong O.
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009706. PubMed ID: 34473691
    [Abstract] [Full Text] [Related]

  • 18. Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni.
    Sanchez MC, Cupit PM, Bu L, Cunningham C.
    Mol Biochem Parasitol; 2019 Mar; 228():6-15. PubMed ID: 30658180
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility or resistance of praziquantel in human schistosomiasis: a review.
    Wang W, Wang L, Liang YS.
    Parasitol Res; 2012 Nov; 111(5):1871-7. PubMed ID: 23052781
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.